Included scope
- One representative system or validation project
- Agreed lifecycle documents and traceability path
- Named pilot users and roles
- Structured onboarding and review checkpoints
30-day controlled pilot
Test PHARPRO DVS in one controlled validation lifecycle.
A structured evaluation for regulated teams that need evidence of workflow fit, traceability, control and business value before rollout.
Validation-specific workflowHuman-reviewed outputControlled evaluationNo confidential data required to start
Pilot outcome
A bounded 30-day evaluation—not an open-ended software trial
The pilot tests one representative validation lifecycle against an agreed baseline. The goal is to decide whether DVS fits your workflow, controls and business case before enterprise rollout.
PHARPRO deliverables
- Pilot charter and intended-use boundary
- Workflow and role configuration record
- Onboarding session and guided execution
- Final fit, control and scale recommendation
Customer inputs
- Pilot owner and quality reviewer
- Approved templates or representative test data
- Current effort baseline
- Availability for review and decision meetings
30-day path
Four gates from scope to scale decision
Scope
Confirm intended use, workflow, users, documents, data boundary and success measures.
Configure
Set roles, pilot workflow and agreed document path; complete onboarding.
Execute
Run the representative lifecycle with controlled review and recorded issues.
Decide
Compare results with baseline and issue a proceed, adjust or stop recommendation.
Success criteria
Agree the measures before the pilot starts
Workflow fit
Can users complete the agreed lifecycle without uncontrolled side processes?
Traceability
Are requirements, risks, tests and review status connected and understandable?
Effort and rework
How does preparation, review and correction compare with the approved baseline?
Control fit
Do roles, review, approval and record controls support the intended process?
User adoption
Can qualified users operate the workflow consistently after onboarding?
Scale decision
What configuration, validation, security or commercial actions remain before rollout?
Frequently asked questions
Questions regulated teams ask first
Is the pilot a production deployment?
No. The pilot is a bounded evaluation of one representative validation lifecycle. Production use requires the customer’s approved implementation, governance and validation decisions.
Do we need to upload confidential GxP data?
No confidential, patient or production data is required for the initial fit check. Pilot data and access boundaries are agreed before configuration.
How is success measured?
The customer and PHARPRO agree a baseline and success criteria before execution, including effort, review cycles, traceability completeness, usability and control fit.
Does a successful pilot mean the platform is automatically validated?
No. The regulated company remains responsible for validating its configured intended use and approving release through its quality system.
Make the next decision with evidence.
Start with a focused evaluation. PHARPRO will confirm fit, required controls and the most defensible next step before asking your team to scale.
Request a DVS evaluation